Model
Edge
Amylyx Pharmaceuticals Inc.
0001913765
Filing Type
4
Filing Date
2/4/2025
Updated
2/5/25, 2:58 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership